ARTemis: Randomized trial with neoadjuvant chemotherapy for patients with early breast cancer

被引：0
|
作者：
Earl, Helena Margaret
Blenkinsop, C.
Grybowicz, L.
Vallier, A-L
Cameron, David A.
Bartlett, John M. S.
Murray, Nicholas
Caldas, Carlos
Thomas, J.
Dunn, Janet A.
Higgins, Helen B.
Hiller, Louise
Hayward, Larry
机构：
[1] Univ Cambridge, Dept Oncol, Cambridge, England
[2] NIHR Cambridge Biomed Res Ctr, Cambridge, England
[3] Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England
[4] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Canc Trials Ctr, Cambridge, England
[5] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[6] Univ Edinburgh, Edinburgh Canc Res Ctr, Endocrine Canc Grp, Edinburgh, Midlothian, Scotland
[7] SA Hlth Author, Adelaide, SA, Australia
[8] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS1144
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Patterns of failure in a randomized trial of adjuvant chemotherapy in postmenopausal patients with early breast cancer treated with tamoxifen
    Arriagada, R
    Spielmann, M
    Koscielny, S
    Le Chevalier, T
    Delozier, T
    Ducourtieux, M
    Tursz, T
    Hill, C
    ANNALS OF ONCOLOGY, 2002, 13 (09) : 1378 - 1386
  • [32] Dose-dense adjuvant chemotherapy in early breast cancer patients: Results from a randomized trial
    Venturini, M
    Del Mastro, L
    Aitini, E
    Baldini, E
    Caroti, C
    Contu, A
    Testore, F
    Brema, F
    Pronzato, P
    Cavazzini, G
    Sertoli, MR
    Canavese, G
    Rosso, R
    Bruzzi, P
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (23): : 1724 - 1733
  • [33] Randomized trial of Tibetan yoga in patients with breast cancer undergoing chemotherapy
    Chaoul, Alejandro
    Milbury, Kathrin
    Spelman, Amy
    Basen-Engquist, Karen
    Hall, Martica H.
    Wei, Qi
    Shih, Ya-Chen Tina
    Arun, Banu
    Valero, Vicente
    Perkins, George H.
    Babiera, Gildy V.
    Wangyal, Tenzin
    Engle, Rosalinda
    Harrison, Carol A.
    Li, Yisheng
    Cohen, Lorenzo
    CANCER, 2018, 124 (01) : 36 - 45
  • [34] Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer: The CamRelief Randomized Clinical Trial
    Chen, Li
    Li, Hui
    Zhang, Hao
    Yang, Huawei
    Qian, Jun
    Li, Zhihua
    Ren, Yu
    Wang, Shu
    Fu, Peifen
    Yang, Hongjian
    Liu, Yunjiang
    Sun, Jing
    Nie, Jianyun
    Lei, Ruiwen
    Yao, Yongzhong
    Zhang, Anqin
    Wang, Shouman
    Ma, Xiaopeng
    Ouyang, Zhong
    Yang, Hongwei
    Wu, Song-Yang
    Cao, Shuo-Wen
    Wang, Kun
    Jiang, Aimei
    Ouyang, Quchang
    Pang, Da
    Wei, Limin
    Zha, Xiaoming
    Shen, Yu
    Qu, Xiangwen
    Wu, Fei
    Zhu, Xiaoyu
    Wang, Zhonghua
    Fan, Lei
    Shao, Zhi-Ming
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024,
  • [35] Patient-reported outcomes from a randomized trial of neoadjuvant atezolizumab-chemotherapy in early triple-negative breast cancer
    Barrios, Carlos H.
    Saji, Shigehira
    Harbeck, Nadia
    Zhang, Hong
    Jung, Kyung H.
    Patel, Sheetal
    Patel, Shilpen
    Anh Nguyen Duc
    Liste-Hermoso, Mario
    Chui, Stephen Y.
    Mittendorf, Elizabeth A.
    NPJ BREAST CANCER, 2022, 8 (01)
  • [36] Conserving surgery in inflammatory breast cancer after neoadjuvant chemotherapy in patients with clinical complete response: the ConSIBreC randomized controlled trial
    Scardina, Lorenzo
    Masetti, Riccardo
    Franceschini, Gianluca
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [37] Vitamin D Supplementation Improves Pathological Complete Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Randomized Clinical Trial
    Omodei, Michelle Sako
    Chimicoviaki, Jackeline
    Buttros, Daniel Araujo Brito
    Almeida-Filho, Benedito Souza
    Carvalho-Pessoa, Carla Priscila
    Carvalho-Pessoa, Eduardo
    Vespoli, Heloisa De Luca
    Nahas, Eliana Aguiar Petri
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2025,
  • [38] Patient-reported outcomes from a randomized trial of neoadjuvant atezolizumab-chemotherapy in early triple-negative breast cancer
    Carlos H. Barrios
    Shigehira Saji
    Nadia Harbeck
    Hong Zhang
    Kyung H. Jung
    Sheetal Patel
    Shilpen Patel
    Anh Nguyen Duc
    Mario Liste-Hermoso
    Stephen Y. Chui
    Elizabeth A. Mittendorf
    npj Breast Cancer, 8
  • [39] Identification of SNPs associated with response of breast cancer patients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trial
    Le Morvan, V.
    Litiere, S.
    Laroche-Clary, A.
    Ait-Ouferoukh, S.
    Bellott, R.
    Messina, C.
    Cameron, D.
    Bonnefoi, H.
    Robert, J.
    PHARMACOGENOMICS JOURNAL, 2015, 15 (01): : 63 - 68
  • [40] Identification of SNPs associated with response of breast cancer patients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trial
    V Le Morvan
    S Litière
    A Laroche-Clary
    S Ait-ouferoukh
    R Bellott
    C Messina
    D Cameron
    H Bonnefoi
    J Robert
    The Pharmacogenomics Journal, 2015, 15 : 63 - 68
12345